Eplus Inc: Form 10-Q for the period ended Dec 31, 2017
Filed with the SEC on Feb 8, 2018 and accepted by EDGAR at Feb 7, 2018, 18:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-10-01 to 2017-12-31 | $265.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2017-04-01 to 2017-12-31 | $838.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-10-01 to 2017-12-31 | $76.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2017-04-01 to 2017-12-31 | $241.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2017-10-01 to 2017-12-31 | $57.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2017-04-01 to 2017-12-31 | $168.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-10-01 to 2017-12-31 | $16.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2017-04-01 to 2017-12-31 | $65.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-10-01 to 2017-12-31 | $678.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2017-04-01 to 2017-12-31 | $19.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-10-01 to 2017-12-31 | $15.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2017-04-01 to 2017-12-31 | $46.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-10-01 to 2017-12-31 | $1.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2017-04-01 to 2017-12-31 | $3.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-10-01 to 2017-12-31 | $1.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2017-04-01 to 2017-12-31 | $3.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-10-01 to 2017-12-31 | 13,990,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2017-04-01 to 2017-12-31 | 14,022,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2017-04-01 to 2017-12-31 | $48.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 9 months2017-04-01 to 2017-12-31 | $13.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $76.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $569.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $764.7m | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $358.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $381.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-12-31 | $383.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001022408-18-000003. Last ingested by Listed: Nov 6, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.